1-201718545-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001389617.1(NAV1):c.1877C>T(p.Ser626Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000155 in 1,613,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001389617.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAV1 | NM_001389617.1 | c.1877C>T | p.Ser626Leu | missense_variant | Exon 7 of 34 | ENST00000685211.1 | NP_001376546.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAV1 | ENST00000685211.1 | c.1877C>T | p.Ser626Leu | missense_variant | Exon 7 of 34 | NM_001389617.1 | ENSP00000510803.1 | |||
NAV1 | ENST00000367296.8 | c.1016C>T | p.Ser339Leu | missense_variant | Exon 3 of 30 | 5 | ENSP00000356265.4 | |||
NAV1 | ENST00000367302.5 | c.1055C>T | p.Ser352Leu | missense_variant | Exon 5 of 30 | 5 | ENSP00000356271.1 | |||
IPO9-AS1 | ENST00000413035.5 | n.685-30132G>A | intron_variant | Intron 2 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152192Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 248954Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134688
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1460816Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 726660
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152192Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1016C>T (p.S339L) alteration is located in exon 3 (coding exon 3) of the NAV1 gene. This alteration results from a C to T substitution at nucleotide position 1016, causing the serine (S) at amino acid position 339 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at